Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRISADE CONTROL
NCT04040192Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2019
- Primary completion
- Jan 2022
- Countries
- 6
01
Overview
A Phase 3 trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by Pfizer. Started Sep 2019; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04040192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04040192.